Bioactive natural compounds for the treatment of gastrointestinal disorders.
Many healthy subjects and patients are taking natural bioactive products for the prevention and treatment of multiple conditions, including gastrointestinal disorders. Based on current evidence, the scientific validity of the use of many of these commercial compounds by the general public is severely limited, with quality control and regulatory issues continuing to be a concern. Nevertheless, there is sufficient preliminary data to warrant further research of these products in order to identify novel compounds for potential clinical use in addition to performing formal randomized controlled clinical trials of the commercial preparations.
Ghosh
Subrata
S
Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, U.K.
Playford
Raymond J
RJ
D000284:Administration, Oral; D000818:Animals; D001905:Botulinum Toxins / Q000627:therapeutic use; D003126:Colostrum; D004063:Digestion; D005227:Fatty Acids; D005395:Fish Oils; D005767:Gastrointestinal Diseases / Q000628:therapy*; D006722:Honey; D006801:Humans; D007778:Lactobacillus; D008892:Milk; D009324:Naturopathy; D010243:Paralysis / Q000188:drug therapy; D008517:Phytotherapy; D011161:Porifera; D019936:Probiotics / Q000627:therapeutic use; D012908:Snails; D015014:Yogurt; D000099219:Royal Jelly
D001905:Botulinum Toxins; D005227:Fatty Acids; D005395:Fish Oils; D000099219:Royal Jelly